Wealthcare Capital Partners’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$496K Sell
10,644
-184
-2% -$8.51K 0.21% 99
2026
Q1
$531K Sell
10,828
-761
-7% -$35.4K 0.25% 81
2025
Q4
$505K Sell
11,589
-4,379
-27% -$200K 0.24% 84
2025
Q3
$719K Buy
15,968
+93
+0.6% +$4.08K 0.33% 56
2025
Q2
$689K Buy
15,875
+120
+0.8% +$5.34K 0.35% 52
2025
Q1
$726K Buy
15,755
+123
+0.8% +$5.14K 0.37% 47
2024
Q4
$588K Buy
+15,632
New +$606K 0.31% 50

Other funds holding EXC

Wealthcare Capital Partners's EXC Position: Q2 2026 in Review

Wealthcare Capital Partners reduced its Exelon (EXC) stake by 1.7% in Q2 2026, selling an estimated $8.51K and leaving 10,644 shares worth $496K. The position accounts for 0.21% of the portfolio, ranked #99.

Wealthcare Capital Partners first reported a position in EXC in Q4 2024 and has held it in 7 quarters since. The position peaked at $726K in Q1 2025. 537 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Wealthcare Capital Partners held 10,644 shares of Exelon worth $496K as of Q2 2026.
  • Wealthcare Capital Partners sold 184 Exelon shares in Q2 2026, an estimated $8.51K.
  • Exelon made up 0.21% of Wealthcare Capital Partners's portfolio in Q2 2026, its #99 holding.
  • Wealthcare Capital Partners first reported a position in Exelon in Q4 2024 and has held it in 7 quarters since.
  • Wealthcare Capital Partners's Exelon position peaked at $726K in Q1 2025.
  • 537 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Wealthcare Capital Partners's 13F filing for Q2 2026, filed 9 Jul 2026.